Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.49
+0.18 (1.59%)
Nov 20, 2024, 4:00 PM EST - Market closed
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $8.36 billion as of November 21, 2024. Its market cap has increased by 16.28% in one year.
Market Cap
8.36B
Enterprise Value
3.46B
1-Year Change
16.28%
Ranking
Category
Stock Price
$11.49
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $8.36B, an increase of 1,468.15%. That is a compound annual growth rate of 100.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 8.36B | -7.35% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intra-Cellular Therapies | 8.74B |
| Masimo | 8.61B |
| Tempus AI | 8.51B |
| Chemed | 8.28B |
| The Ensign Group | 8.21B |
| Glaukos | 7.55B |
| Bruker | 7.49B |
| Walgreens Boots Alliance | 7.49B |